Market revenue in 2023 | USD 305.3 million |
Market revenue in 2030 | USD 411.8 million |
Growth rate | 4.4% (CAGR from 2023 to 2030) |
Largest segment | Devices |
Fastest growing segment | Drugs |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Devices, Drugs |
Key market players worldwide | Novartis AG ADR, Frequency Therapeutics, Acousia Therapeutics, Sensorion, Pipeline Therapeutics, Audina Hearing Instruments, Astellas Pharma Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hearing loss disease treatment market will help companies and investors design strategic landscapes.
Devices was the largest segment with a revenue share of 90.04% in 2023. Horizon Databook has segmented the South Korea hearing loss disease treatment market based on devices, drugs covering the revenue growth of each sub-segment from 2018 to 2030.
Increase in awareness among people and rise in government support are expected to drive the hearing loss disease treatment market in South Korea. In April 2020, UFIRST Co., Ltd announced the launch of NUGUNA HEARING-AID, which has the capability to detect high-pitched sound and provide information about the direction of high-pitched sound source.
Furthermore, in June 2019, Starkey announced launch of its new AI-based hearing aid in South Korea market. In addition, increasing involvement of market players for collaborations and partnerships is also expected to have a positive impact on the market growth.
For instance, in June 2022, Digital Pharm, a Korean company in digital treatment devices, entered into a strategic collaboration with KT Corporation and Hanmi Pharmaceutical. The partnership is also expected to address diseases associated with hearing loss.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea hearing loss disease treatment market, including forecasts for subscribers. This country databook contains high-level insights into South Korea hearing loss disease treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account